Why Invest in Smylor?

Having compared Smylor with other doctor based marketplaces such as Kry and Doctolib, Smylor offers investors a potentially disruptive dentistry marketplace outpacing current incumbents in terms of growth, margin and FCF going forward. Early investors have the potential to participate and benefit from Symlor significantly increasing its valuation multiple in a relatively short period of time. We anticiapte within 5 years to achieve a valuation of over €250m on investors's equity...

IT Sector Analyst, Prestigious and Globally operating Private Bank